Sponsor pipeline

Gustave Roussy, Cancer Campus, Grand Paris clinical trial pipeline

Get alerts when Gustave Roussy, Cancer Campus, Grand Paris's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-13 NCT07871864 Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to… Phase 3 Recruiting

Active trials by phase

Phase 1
4
Phase 1/2
4
Phase 2
17
Phase 3
22
Phase 4
2
Not charted: 24 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 30

Breast Cancer (11) · Lung Cancer (10) · Head & Neck Cancer (7) · Colorectal Cancer (6) · Sarcoma (6) · Kidney Cancer (5) · Non-Small Cell Lung Cancer (NSCLC) (5) · Pancreatic Cancer (5) · Prostate Cancer (4) · Leukemia (3)

Get alerts when Gustave Roussy, Cancer Campus, Grand Paris's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free